PRESS RELEASE published on 05/27/2025 at 07:30, 1 year 1 month ago Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025 pour le lancement d'essais cliniques de Phase 3 de NCX 470 au Japon, prolongeant ainsi leur horizon de trésorerie Essais Cliniques Nicox Horizon De Trésorerie Kowa Paiements D'étapes
BRIEF published on 05/14/2025 at 07:35, 1 year 2 months ago Nicox Reports Findings from Whistler Phase 3b Glaucoma Trial Glaucoma Nicox NCX 470 Whistler Phase 3b Intraocular Pressure
BRIEF published on 05/14/2025 at 07:35, 1 year 2 months ago Nicox publie les résultats de l'essai de phase 3b sur le glaucome à Whistler Nicox NCX 470 Glaucome Whistler Phase 3b Pression Intraoculaire
PRESS RELEASE published on 05/14/2025 at 07:30, 1 year 2 months ago Nicox Announces Results of the Exploratory Whistler Phase 3b Glaucoma Trial Nicox announces positive results of Whistler Phase 3b glaucoma trial with NCX 470 showing efficacy in lowering intraocular pressure via dual mechanism action of nitric oxide and prostaglandin analogs. Safety profile consistent with previous trial Nicox NCX 470 Glaucoma Trial Whistler Phase 3b Intraocular Pressure
BRIEF published on 04/30/2025 at 07:35, 1 year 2 months ago Nicox Reports Full Year 2024 Financials Net Loss Cash Reserves Nicox Financial Results VYZULTA Revenue Sale NCX 470 Trials
BRIEF published on 04/30/2025 at 07:35, 1 year 2 months ago Nicox publie ses résultats financiers pour l'année 2024 Perte Nette Réserves De Trésorerie Résultats Financiers De Nicox Vente De Revenus De VYZULTA Essais NCX 470
PRESS RELEASE published on 04/30/2025 at 07:30, 1 year 2 months ago Nicox Provides Full Year 2024 Financial Results Nicox reports €7.9 million revenue for 2024 with exceptional income of €13.7 million from VYZULTA transfer. Cash of €10.5 million and NCX 470 Phase 3 trial results expected in Q3 2025 Financial Results Revenue Nicox NCX 470 VYZULTA
PRESS RELEASE published on 04/30/2025 at 07:30, 1 year 2 months ago Nicox : Résultats financiers de l’année 2024 Nicox annonce résultats financiers 2024, incluant CA de 7,9M€, produits exceptionnels de 13,7M€ et trésorerie de 10,5M€. Études cliniques NCX 470 en cours Résultats Financiers Trésorerie Études Cliniques Nicox NCX 470
BRIEF published on 03/19/2025 at 07:35, 1 year 3 months ago Nicox Completes Final Visit for NCX 470 Phase 3b Whistler Glaucoma Trial Glaucoma Nicox Clinical Results NCX 470 Phase 3b Trial
BRIEF published on 03/19/2025 at 07:35, 1 year 3 months ago Nicox a terminé la dernière visite de l'essai de phase 3b NCX 470 sur le glaucome à Whistler Nicox Résultats Cliniques NCX 470 Glaucome Essai De Phase 3b
Published on 07/14/2026 at 22:30, 2 hours 44 minutes ago Hillcrest Energy Technologies Announces Board and Leadership Changes Following 2026 Annual General Meeting
Published on 07/14/2026 at 22:30, 2 hours 44 minutes ago Loop Industries Reports First Quarter Fiscal 2027 Results and Provides Update on Progress Towards Commercialization
Published on 07/14/2026 at 16:40, 8 hours 34 minutes ago AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 9 hours 29 minutes ago Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 23:48, 1 hour 26 minutes ago North Peak Announces Proposed Extension of Warrant Expiry Date
Published on 07/14/2026 at 19:14, 6 hours ago EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 6 hours 57 minutes ago EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 7 hours 23 minutes ago Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 7 hours 44 minutes ago NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/13/2026 at 18:00, 1 day 7 hours ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 7 hours ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 7 hours ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026